FATE
Fate Therapeutics, Inc.Closed2.00−0.13 −6.10%USD
NasdaqGM · as of Oct 13, 16:00 ET · 15m delayAfter hours 2.00 0.00%
Open
2.13
Prev close
2.13
Day range
1.982.13
52-week range
0.95003.23
Volume
952.47K0.57×
Mkt cap
239.64M
P/E ttm
—
Fwd P/E
-2.07
EPS ttm
-1.05
Div yield
0.00%
Earnings
Aug 13, 2026
From 52w high
−38.08%
FATE earnings and estimates
FATE Next Report
Yahoo Finance · Nasdaq
Report date
Thu, Nov 12
Before the open · estimated
EPS consensus
$−0.26
range −0.28 – −0.21
EPS growth vs year ago
+5.6%
year ago −0.27
Revenue consensus
$1.20M
−30.9% vs year ago
Options-implied move
±31.3%
by Nov 20 · ATM straddle
Past 4 reactions
±5.6%
average move · beat 4 of 4
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Aug 13, 2026 BMO | −0.25 | −0.26 | +2.60% | — | −7.4% | −2.6% |
| Mar '26 | May 13, 2026 BMO | −0.26 | −0.28 | +5.45% | $1.30M | −4.9% | −16.0% |
| Dec '25 | Feb 26, 2026 BMO | −0.27 | −0.27 | +0.46% | $1.37M | +5.4% | −2.0% |
| Sep '25 | Nov 13, 2025 BMO | −0.27 | −0.28 | +4.33% | $1.74M | −4.8% | +1.0% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −0.26 | −0.28−0.21 | +5.6% | $1.20M | −30.9% | −0.26 0.0% | −0.26 +2.8% | 4 / 2 |
| Next quarter Dec 2026 | −0.27 | −0.34−0.22 | 0.0% | $1.20M | −12.2% | −0.27 0.0% | −0.28 +2.0% | 3 / 3 |
| Current year Dec 2026 | −1.02 | −1.11−0.88 | +11.5% | $5.65M | −15.0% | −1.02 0.0% | −1.03 +1.5% | 4 / 2 |
| Next year Dec 2027 | −0.97 | −1.30−0.64 | +4.9% | $4.77M | −15.6% | −0.97 0.0% | −0.99 +2.1% | 3 / 1 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Forward EPS Forecasts
Nasdaq · Zacks consensus
Quarterly
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Sep 2026 | −0.27 | −0.28−0.26 | 4 | 0 / 0 |
| Dec 2026 | −0.30 | −0.34−0.28 | 4 | 0 / 0 |
| Mar 2027 | −0.25 | −0.28−0.23 | 2 | 0 / 0 |
| Jun 2027 | −0.26 | −0.29−0.23 | 2 | 0 / 0 |
| Sep 2027 | −0.27 | −0.30−0.24 | 2 | 0 / 0 |
Fiscal years
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Dec 2026 | −1.03 | −1.11−0.82 | 6 | 0 / 0 |
| Dec 2027 | −1.01 | −1.30−0.56 | 5 | 0 / 0 |
| Dec 2028 | −1.21 | — | 1 | 0 / 0 |
| Dec 2029 | −1.28 | — | 1 | 0 / 0 |
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.